A systematic review of regimens for prevention of active tuberculosis in HIV-negative individuals with latent TB found that a weekly, directly observed regimen of<unk>  with isoniazid for three months was as effective as a daily, self-administered regimen of isoniazid for nine months. The three-month<unk> -isoniazid regimen had higher rates of treatment completion and lower rates of hepatotoxicity. However, the rate of treatment-limiting adverse events was higher in the<unk> -isoniazid regimen compared to the nine-month isoniazid regimen. Pregnancy<unk>  has been assigned a pregnancy category C by the U.S. Food and Drug Administration (FDA).<unk>  in pregnant women has not been studied, but animal reproduction studies have resulted in fetal harm and were teratogenic. If<unk>  or rifampin are used in late pregnancy, coagulation should be monitored due to a possible increased risk of maternal postpartum hemorrhage and infant bleeding.
Rifapentine
Piretanide
Albendazole
Amifampridine
Artemether
Tiabendazole
Avermectin
Praziquantel